Arbutus Biopharma
ABUS
#6327
Rank
A$0.98 B
Marketcap
$5.14
Share price
-1.50%
Change (1 day)
23.32%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -A$0.11 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are A$6.17 Million. , an increase over its 2023 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.11 Billion-4.02%
2023 -A$0.12 Billion12.05%
2022 -A$0.11 Billion-14.74%
2021 -A$0.12 Billion19.61%
2020 -A$99.64 Million-61.69%
2019 -A$0.27 Billion171.23%
2018 -A$95.88 Million-43.58%
2017 -A$0.17 Billion-77.77%
2016 -A$0.77 Billion532.77%
2015 -A$0.13 Billion99.05%
2014 -A$60.71 Million175.82%
2013 -A$22.01 Million-143.7%
2012 A$50.36 M-399.11%
2011 -A$16.84 Million-39.03%
2010 -A$27.62 Million100.55%
2009 -A$13.78 Million-28.56%
2008 -A$19.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$55.14 M-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.38 Million-96.91% Bahamas